Last reviewed · How we verify
Icosapent (Eicosapentaenoic acid)
At a glance
| Generic name | Eicosapentaenoic acid |
|---|---|
| Also known as | Omega-3 fatty acid, Lovaza, EPA, omega-3-acid ethyl esters, docosahexaenoic acid |
| Sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Target | Peroxisome proliferator-activated receptor alpha |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Breastfeeding (mother)
- Pregnancy, function
Common side effects
- Allergic sensitization
Key clinical trials
- Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia (PHASE2)
- Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions (NA)
- OMEGA - Dietary Intervention - COPD Trial (NA)
- Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids (NA)
- NUTRIBRAIN: Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice (POWER) (NA)
- Observing Metabolism of EPA With Consideration of Genetics And Sex (PHASE4)
- NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status (NA)
- Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Icosapent CI brief — competitive landscape report
- Icosapent updates RSS · CI watch RSS
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) portfolio CI